Conservative management may be safe for retained central venous catheter fragments in children

Share :
Published: 24 Sep 2026
Views: 0
Rating:
Save
Dr Alessandro Crocoli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Dr Alessandro Crocoli speaks to ecancer about a 15-year retrospective study examining difficult central venous catheter removal in children.

He reports that difficult removal was rare, occurring in less than 1% of more than 3,000 procedures, and was particularly associated with prolonged catheter dwell times and chronic disease.

Dr Crocoli explains that almost half of the difficult cases resulted in a retained catheter fragment, with affected patients managed conservatively without subsequent late complications.

He highlights a shift from aggressive attempts at complete extraction towards a more conservative approach, suggesting that leaving retained intravascular fragments in place may be a safe option for selected asymptomatic patients when standard catheter removal fails.

Related Videos

P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer

Dr Michele Milella - University of Verona, Verona, Italy
P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer ( Dr Michele Milella - University of Verona, Verona, Italy )
17 Jul 2026

First-in-human study of in vivo CAR-T therapy shows promising activity in relapsed or refractory B-cell non-Hodgkin lymphoma

Dr Ying Huang - CEO, Legend Biotech
First-in-human study of in vivo CAR-T therapy shows promising activity in relapsed or refractory B-cell non-Hodgkin lymphoma ( Dr Ying Huang - CEO, Legend Biotech )
19 Jun 2026

Durvalumab plus chemotherapy improves survival in extensive-stage small cell lung cancer regardless of tumour laterality

Dr Lorenza Landi - National Cancer Institute Regina Elena, Rome, Italy
Durvalumab plus chemotherapy improves survival in extensive-stage small cell lung cancer regardless of tumour laterality ( Dr Lorenza Landi - National Cancer Institute Regina Elena, Rome, Italy )
15 Apr 2026

Ultra-sensitive ctDNA detects residual disease and predicts recurrence early in RCC

Dr Taigo Kato - The Univeristy of Osaka, Suita, Japan
Ultra-sensitive ctDNA detects residual disease and predicts recurrence early in RCC ( Dr Taigo Kato - The Univeristy of Osaka, Suita, Japan )
18 Mar 2026

Pirtobrutinib significantly improves PFS in treatment-naïve CLL/SLL compared to bendamustine plus rituximab

Prof Wojciech Jurczak - Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
Pirtobrutinib significantly improves PFS in treatment-naïve CLL/SLL compared to bendamustine plus rituximab ( Prof Wojciech Jurczak - Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland )
18 Dec 2025

Longer follow-up shows promising PFS + MRD negativity for mosunetuzumab use in untreated high tumour burden follicular lymphoma

Dr John Burke - Rocky Mountain Cancer Centers, Aurora, USA
Longer follow-up shows promising PFS + MRD negativity for mosunetuzumab use in untreated high tumour burden follicular lymphoma ( Dr John Burke - Rocky Mountain Cancer Centers, Aurora, USA )
18 Dec 2025

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA
Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Oct 2025

Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations

Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations ( Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden )
14 Feb 2025

Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast cancer

Prof Robert Hills - University of Oxford, Oxford, United Kingdom
Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast cancer ( Prof Robert Hills - University of Oxford, Oxford, United Kingdom )
18 Dec 2024